You can narrow down the results using the filters
-
The effect of varying remifentanil infusion rates on target controlled infusion propofol concentrations necessary to maintain anaesthesia as assessed by bi-spectral index
Expand description -
Essential Fatty Acid Supplementation in Psychosis
Expand descriptionThis study investigates the influence of Eicosapentanoic acid (EPA) in first episode psychotic patients. The influence of EPA supplementation has been investigated only in neuroleptic-treated, mostly chronic patients with schizophrenia. The effect size of EPA supplementation in addition to antipsychotic treatment in these studies was approximately 20%. We suggest that the effect in early course of illness is even stronger and long-term consequences could be avoided. For ethical reasons at this point ALL patients get a standard treatment with an atypical antipsychotic (standard treatment for first episode patients at EPPIC) in a flexible dose regime. After inclusion into the study patients are randomised to two arms. One arm will be supplemented with a mineral oil (4 capsules of 0.5g) which is not absorbed by the gastrointestinal tract (placebo group). The other arm will be supplemented with purified Eicosapentanoic acid (4 capsules of 0.5g). Patients who give written informed consent will do standard clinical and neuropsychological tests (CANTAB) at baseline and after 12 weeks of supplementation (pre/post study design). A topical Niacin flush test (already approved by the research and ethics committee within following project: Psychobiology and Prevention of Transition to Psychosis 29/7/99) will also be applied at baseline and after 12weeks.
-
A Randomised Controlled Trial of an Expert Weaning System (SmartcareTM) versus Usual Ventilatory Management in Critical Illness
Expand description -
Intervention to improve quality use of medicines in elderly people: effect on health outcomes.
Expand description -
Cumberland Low Back Pain Trial
Expand description -
Assessment of Diabetes after Periodontal Treatment
Expand description -
New approaches in genetic analysis to predict for CRC risk.
Expand descriptionTo find the undiscovered gene or genes responsible for hereditary colorectal cancer, and to understand how the gene(s) cause colorectal cancer.
-
The antioxidant and immunomodulatory effects of Ambrotose AO in healthy smokers and non-smokers
Expand descriptionThe project was an open label, forced titration dose response study conducted over 5 weeks in 10 healthy smokers and 10 healthy non-smokers. Twenty-two subjects were enrolled in the study and were similarly treated with the study medication. Data was collected at baseline and then each week for a further 5 weeks.
-
A Follow-up Study of the Efficacy of a Complementary Medicine Formulation in Primary Hypercholesterolemia
Expand descriptionA follow-up study to determine the efficacy and safety profile of a natural medicine formulation in lowering lipid levels in primary hypercholesteremia over a 6-month period. The study also looked at the effect of the preparation on coenzyme Q10 levels.Study blood parameters were measured every 4 weeks
-
The Effects of Individualised and Complex Homeopathic Treatment in Osteoarthritis using a Novel Research design
Expand descriptionThe purpose of the study is to compare the effects of traditional homeopathic treatment, a generic homeopathic treatment with placebo on symptoms of osteoarthritis of the hip and/or knee.